Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinically relevant evidence on imaging and artificial intelligence in hidradenitis suppurativa.

Created on 21 Sep 2026

Authors

Ximena Wortsman, Mehdi Boostani, Norbert Kiss, Valentina Dini, Dimitrios Ioannidis

Published in

Journal of the European Academy of Dermatology and Venereology : JEADV. Sep 21, 2026. Epub Sep 21, 2026.

Abstract

This review provides a comprehensive analysis of the role of imaging and artificial intelligence in hidradenitis suppurativa (HS), highlighting the strengths and limitations of each modality and providing the level of evidence for each imaging technique. To date, ultrasound has emerged as the only modality with validated diagnostic criteria, standardized scoring systems and strong international multicentre evidence and consensus, supporting its role as the first-line tool for diagnosis, staging, pre-surgical mapping and treatment guidance in HS. Other techniques, such as dermoscopy, magnetic resonance imaging (MRI), computed tomography (CT), Positron Emission Tomography (PET)-CT, optical coherence tomography (OCT), medical infrared thermography and reflectance confocal microscopy (RCM), serve complementary or limited roles with a lower level of evidence in HS. Emerging artificial intelligence (AI) applications show promise for improving early detection, standardizing severity assessment and optimizing clinical workflows, though further validation and multicentre studies are required.

PMID:
42765561
Bibliographic data and abstract were imported from PubMed on 21 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 31
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement